Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Oxford Biodynamics director lowers stake

(Sharecast News) - Oxford Biodynamics revealed on Friday that Vulpes Testudo Fund had offloaded 777,000 ordinary shares in the AIM-listed biotechnology company. Vulpes Testudo, which is controlled by non-executive director Stephen Diggle, sold the shares on Wednesday at an average price of 38.30p each, for a total value of £297,590.99.

Following the transaction, Diggle holds an interest in a total of 27.55m OBD shares, representing approximately 13.62% of the company's current issued share capital.

Earlier in October, Oxford BioDynamics successfully secured a proprietary laboratory analysis (PLA) code from the American Medical Association's Current Procedural Terminology Editorial Board. OBD said the unique code pertained to its EpiSwitch prostate screening test, which boasts a 94% accuracy.

As of 1530 BST, Oxford Biodynamics shares were up 2.25% at 34.80p.

Reporting by Iain Gilbert at

Top Director Buys

Everyman Media Group (EMAN) Director name: Rosehill,Michael Amount purchased: 2,500,000 @ 55.00p Value: �1,375,000.03

Oxford Cannabinoid Technologies Holdings (OCTP) Director name: Mahapatra,Indraneil (Neil) Amount purchased: 20,457,484 @ 0.81p Value: �165,705.62

888 Holdings (di) (888) Director name: Mendelsohn,Jonathan (Jon) Amount purchased: 50,000 @ 79.50p Value: �39,750.00

Top Director Sells

Ferguson (FERG) Director name: Murphy,Kevin Amount sold: 18,619 @ $164.54 Value: $2,526,213.08

Oxford Cannabinoid Technologies Holdings (OCTP) Director name: Mahapatra,Indraneil (Neil) Amount sold: 54,864,288 @ 0.81p Value: �444,400.74

Oxford Biodynamics (OBD) Director name: Diggle,Stephen Charles Amount sold: 777,000 @ 38.30p Value: �297,590.99

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.